Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series
- PMID: 18706688
- DOI: 10.1016/S0140-6736(08)61125-3
Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series
Abstract
Background: Indonesia has had the most human cases of highly pathogenic avian influenza A (H5N1) and one of the highest case-fatality rates worldwide. We described the factors associated with H5N1 case-fatality in Indonesia.
Methods: Between June, 2005, and February, 2008, there were 127 confirmed H5N1 infections. Investigation teams were deployed to investigate and manage each confirmed case; they obtained epidemiological and clinical data from case-investigation reports when possible and through interviews with patients, family members, and key individuals.
Findings: Of the 127 patients with confirmed H5N1 infections, 103 (81%) died. Median time to hospitalisation was 6 days (range 1-16). Of the 122 hospitalised patients for whom data were available, 121 (99%) had fever, 107 (88%) cough, and 103 (84%) dyspnoea on reaching hospital. However, for the first 2 days after onset, most had non-specific symptoms; only 31 had both fever and cough, and nine had fever and dyspnoea. Median time from onset to oseltamivir treatment was 7 days (range 0-21 days); treatment started within 2 days for one patient who survived, four (36.4%) of 11 receiving treatment within 2-4 days survived, six (37.5%) of 16 receiving treatment within 5-6 days survived, and ten (18.5%) of 44 receiving treatment at 7 days or later survived (p=0.03). Initiation of treatment within 2 days was associated with significantly lower mortality than was initiation at 5-6 days or later than 7 days (p<0.0001). Mortality was lower in clustered than unclustered cases (odds ratio 33.3, 95% CI 3.13-273). Treatment started at a median of 5 days (range 0-13 days) from onset in secondary cases in clusters compared with 8 days (range 4-16) for primary cases (p=0.04).
Interpretation: Development of better diagnostic methods and improved case management might improve identification of patients with H5N1 influenza, which could decrease mortality by allowing for earlier treatment with oseltamivir.
Comment in
-
Minimum dataset needed for confirmed human H5N1 cases.Lancet. 2008 Aug 30;372(9640):696-7. doi: 10.1016/S0140-6736(08)61126-5. Epub 2008 Aug 14. Lancet. 2008. PMID: 18706687 No abstract available.
Similar articles
-
Recognizing true H5N1 infections in humans during confirmed outbreaks.J Infect Dev Ctries. 2014 Feb 13;8(2):202-7. doi: 10.3855/jidc.3329. J Infect Dev Ctries. 2014. PMID: 24518630
-
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.Lancet. 2008 Apr 26;371(9622):1427-34. doi: 10.1016/S0140-6736(08)60493-6. Epub 2008 Apr 8. Lancet. 2008. PMID: 18400288
-
[Influenza type A (H5N1) virus infection].Mikrobiyol Bul. 2007 Jul;41(3):485-94. Mikrobiyol Bul. 2007. PMID: 17933264 Review. Turkish.
-
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006.J Infect Dis. 2007 Aug 15;196(4):522-7. doi: 10.1086/519692. Epub 2007 Jun 29. J Infect Dis. 2007. PMID: 17624836
-
Influenza virus A (H5N1): a pandemic risk?New Microbiol. 2007 Apr;30(2):65-78. New Microbiol. 2007. PMID: 17619249 Review.
Cited by
-
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond.Cells. 2022 Jul 14;11(14):2198. doi: 10.3390/cells11142198. Cells. 2022. PMID: 35883640 Free PMC article. Review.
-
The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice.Front Immunol. 2022 May 18;13:859033. doi: 10.3389/fimmu.2022.859033. eCollection 2022. Front Immunol. 2022. PMID: 35663985 Free PMC article.
-
Knowledge, attitude, and practices associated with avian influenza among undergraduate university students of East Java Indonesia: A cross-sectional survey.F1000Res. 2022 Jan 28;11:115. doi: 10.12688/f1000research.74196.1. eCollection 2022. F1000Res. 2022. PMID: 35340276 Free PMC article.
-
Rapid and Efficient Cell-to-Cell Transmission of Avian Influenza H5N1 Virus in MDCK Cells Is Achieved by Trogocytosis.Pathogens. 2021 Apr 16;10(4):483. doi: 10.3390/pathogens10040483. Pathogens. 2021. PMID: 33923524 Free PMC article.
-
Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections.Epidemiol Infect. 2019 Jan;147:e213. doi: 10.1017/S095026881900102X. Epidemiol Infect. 2019. PMID: 31364549 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical